Africa sets sights on innovative mRNA jab to help meet vaccine gap

medicalxpress.com · 799 words · saved by 1 readers

South African biotech consortium is working on a messenger RNA jab based on the Moderna formula in a ground-breaking drive to end Africa's life-threatening lack of COVID vaccines.

A medical assistant prepares a dose of a COVID-19 vaccine to be administered to a patient. Credit: Public domain image courtesy of Lisa Ferdinando, U.S. Department of Defense South African biotech consortium is working on a messenger RNA jab based on the Moderna formula in a ground-breaking drive to end Africa's life-threatening lack of COVID vaccines. Cape Town-based Afrigen Biologics and Vaccines is leading a pilot project, backed by the UN's World Health Organization (WHO) and the COVAX initiative, which seeks to tweak Moderna's revolutionary drug. The goal is an mRNA vaccine that…

related reading

First African-made mRNA vaccine, a test platform for the futurenature.com
Why we didn't get a malaria vaccine sooner - Works in Progress Magazineworksinprogress.co
Progress Deferred: mRNA Vaccine Development Lessons | IFPifp.org
Making Vaccine — LessWronglesswrong.com
Why are mRNA vaccines so exciting? - Harvard Healthhealth.harvard.edu
Why were Covid vaccine trials so fast?substack.com
The story of mRNA: From a loose idea to a tool that may help curb Covidstatnews.com
The story of VaccinateCA - Works in Progress Magazineworksinprogress.co
The Bingwa Initiative – how young people have boosted Africa’s COVID-19 vaccination campaigns – Healthy DEvelopmentshealth.bmz.de
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discoverynature.com
Home - The Africa Pandemic Sciences Collaborativeafricapandemicsciences.org
The golden age of vaccine development - Works in Progress Magazineworksinprogress.co